Alkem Launches 'PRAYAS': A Bold Step Toward Accessible Cancer Care Deeksha Bhandari4 July 2025 12:00 PM ISTIn a significant patient-centric move, Alkem Laboratories Ltd., one of India's largest pharmaceutical companies, has launched PRAYAS- a...
USV Launches Concordance Tool to Empower Gestational Diabetes Care in India Deeksha Bhandari21 Jun 2025 11:00 AM ISTUSV, an Indian multinational healthcare company and holds the #1 position by prescriptions in the Oral Anti-Diabetic and Cardiology markets, has...
Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD Deeksha Bhandari20 Jun 2025 12:00 PM ISTIn a first move Ajanta pharma one of the leaders in the cardiology segment, has announced the launch of Met XL AMT 25 mg. It is a triple-drug...
Alkem's Revolutionary therapy TERIPARATIDE-GEMFRAC for weak bones now more accessible to all Indians Deeksha Bhandari12 Jun 2025 11:33 AM ISTIn a bid to make osteoporosis treatment affordable to Indian masses, Alkem Laboratories has slashed the price of its Teriparatide brand, Gemfrac.Until...
Micro Labs Launches Sitanorm-E, Sitagliptin-Empagliflozin FDC for Uncontrolled Type 2 Diabetes in India Deeksha Bhandari6 Jun 2025 12:11 PM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin. The combination is formulated to...
Sun Pharma Sets Record with Over 1 Lakh Uric Acid Screenings in 3 Days Deeksha Bhandari30 May 2025 1:07 PM ISTSun Pharmaceuticals has achieved a significant milestone by setting a national record for screening the highest number of individuals for uric acid...
Revolutionizing Medical Education: How AI is Accelerating CBME Implementation in India Deeksha Bhandari27 May 2025 11:46 AM ISTIndia is at a pivotal juncture in reshaping its healthcare ecosystem, driven by a burgeoning population, technological advancements, and a renewed...
Micro Labs Launches Sitanorm E: Sitagliptin + Empagliflozin FDC for diabetes patients in India Deeksha Bhandari26 May 2025 11:40 AM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin for the management of ...
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
Ajanta Pharma Sets Worldwide Record for CPR Pledges MDTV Bureau9 May 2025 5:22 PM ISTAjanta Pharma has achieved a significant milestone by entering the Worldwide Book of Records for organizing the maximum number of pledges to train and...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
